Reviews, Book Chapers, and Commentaries

  • Hoppstädter J, Kiemer AK. 2023. Control of CAR-T cell activity in space and time: the next level of anti-tumor action. Signal Transduct Target Ther in press 
  • Kiemer AK. 2020. Blockade of an innate immune amplifier to fight immune hyperactivation in COVID-19? eBioMedicine, Commentary 61:103086
  • Stunnenberg HG, Abrignani S, Adams D, (…) Kiemer AK, (…), Hirst M. 2016. The International Human Epigenome Consortium: a blueprint for scientific collaboration and discovery. Cell 167:1145-1149
  • Kessler SM, Haybaeck J, Kiemer AK. 2016. Insulin-like growth factor 2 - the oncogene and its accomplices. Curr Pharm Des PMID: 27412171
  • Smolle E, Kessler SM, Golob N, Haybaeck J. 2016. Non-Alcoholic Fatty Liver Disease In: Ahima, Rexford S. (eds). Metabolic Syndrome: A Comprehensive Textbook, Springer International Publishing Switzerland 641-65
  • Kessler SM, Simon Y, Laggai S, Kiemer AK. 2013. Erst schwillt sie, dann schrumpft sie - die Rolle von p62 in Lebererkrankungen. Magazin Forschung (Universität des Saarlandes) 2:14-21
  • Kiemer AK, Diesel B. 2008. Activation of cytoprotective signalling pathways by alpha-lipoic acid. In: Patel MS, Packer L (eds.): Alpha-Lipoic Acid: Energy Production, Antioxidant Activity, and Health Effects, Taylor & Francis Ltd., UK
  • Kiemer AK, 2008. Innate immune system: Toll-like receptors open access to new therapy options [Toll-like Rezeptoren eröffnen Zugang zu neuen Therapieoptionen]. Pharmazeutische Zeitung 153: 16-22
  • Kiemer AK, Diesel B. 2006. Mechanismen der Gefäßentzündungen: reaktive Sauerstoffspezies als Schädigungs- und Schutzmechanismus? Magazin Forschung (Universität des Saarlandes) 2:2-8
  • Kiemer AK, Fürst R, Vollmar AM. 2005. Vasoprotective actions of the Atrial Natriuretic Peptide. Curr Med Chem – cardiovascular and haematological agents. 3:11-2
  • Vollmar AM, Kiemer AK. 2004. Natriuretic peptides and inflammation. In: Geenen V, Chrousos G (eds.): Immunoendocrinology in Health and Disease,Marcel Dekker, New York, pp305-318
  • Vollmar AM, Kiemer AK. 2002. Modulation of macrophage function by Atrial Natriuretic Peptide. Recent Res Devel Endocrinol 2:303-315
  • Kiemer AK. 2002. Der Electrophoretic Mobility Shift Assay (EMSA) als Methode zum Nachweis aktivierter Transkriptionsfaktoren. Immunologie Aktuell 2 :107-111
  • Vollmar AM, Kiemer AK. 2001. Immunomodulatory and cytoprotective function of Atrial Natriuretic Peptide. Crit Rev Immunol 1:473-485
  • Kiemer AK. Vollmar AM. 2001. The Atrial Natriuretic Peptide regulates the production of inflammatory mediators in macrophages. Ann Rheum Dis 60 (Suppl III):68-70
  • Kiemer AK. 2000. Das Atriale Natruretische Peptid – ein kardiovaskuläres Hormon moduliert Makrophagenfunktion. Immunologie Aktuell 1:56-57
  • Bilzer M, Schauer RJ, Kiemer AK, Baron A, Vollmar AM, Messmer K, Gerbes AL. 2000. Potential of preconditioning. In: Gerbes AL et al. (eds.): Hepatology 2000, Falk Symposium Nr. 117, Kluwer academic publishers, Lancaster, England, pp 270-278